"10.1371_journal.pone.0112767","plos one","2014-11-18T00:00:00Z","Konstantinos Sombolos; Demitrios Tsakiris; John Boletis; Demetrios Vlahakos; Kostas C Siamopoulos; Vassilios Vargemezis; Pavlos Nikolaidis; Christos Iatrou; Eugene Dafnis; Konstantinos Xynos; Christos Argyropoulos","Nephrology Clinic, Papanikolaou Hospital, Thessaloniki, Greece; Nephrology Clinic, Papageorgiou Hospital, Thessaloniki, Greece; Nephrology Clinic, Laiko Hospital, Athens, Greece; Nephrology Clinic, ATTIKON University Hospital, Athens, Greece; Nephrology Clinic, Ioannina University Hospital, Ioannina, Greece; Nephrology Clinic, Alexandroupoli University Hospital, Alexandroupoli, Greece; Nephrology Clinic, AHEPA Hospital, Thessaloniki, Greece; Center for Nephrology, G Papadakis, Nikea Hospital, Athens, Greece; Nephrology Clinic, PE.PA.G.N.I, Crete University Hospital, Iraklio, Greece; AbbVie Pharmaceuticals, Chicago, Illinois, United States of America; AbbVie Pharmaceuticals SA, Athens, Greece","Conceived and designed the experiments: KX. Performed the experiments: KS DT JB DV KCS VV PN CI ED. Analyzed the data: CA. Wrote the paper: KS DT JB DV KCS VV PN CI ED KX CA.","Drs. SK, DT, JB, DV, KS, VV, PV, CI, and ED are clinician investigators responsible for enrolling patients and collecting the data; they all received investigator fees for their participation in PRESTAR. Dr. KX is a former Abbott (now AbbVie) employee and may own Abbott/AbbVie stock, while Dr. CA was an Abbott Laboratories Hellas (now AbbVie Pharmaceuticals SA) Medical Affairs contractor. Abbott Laboratories funded this study. There are no patents, products in development or marketed products to declare. This does not alter the authors' adherence to all the PLOS ONE policies on sharing data and materials.","2014","11","Konstantinos Sombolos","KS",11,TRUE,1,9,1,11,TRUE,FALSE,FALSE,0,NA,FALSE
